✦ LIBER ✦

Selenium and cancer risk in CHEK2 mutation carriers

✍ Scribed by Satish Gupta; Katarzyna Jaworska; Katarzyna Durda; Grzegorz Sukiennicki; Magdalena Muszyńska; Anna Jakubowska; Jan Lubinski

Book ID: 115027867
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 63 KB
Volume: 10
Category: Article
ISSN: 1897-4287
DOI: 10.1186/1897-4287-10-s3-a19

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Excess Risk for Contralateral Breast Can

Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers

✍ Annegien Broeks; Lot de Witte; Anke Nooijen; Angelina Huseinovic; Jan G.M. Klijn 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 48 KB

Mutations in CHEK2 Associated with Prost

Mutations in CHEK2 Associated with Prostate Cancer Risk

✍ Xiangyang Dong; Liang Wang; Ken Taniguchi; Xianshu Wang; Julie M. Cunningham; Sh 📂 Article 📅 2003 🏛 American Society of Human Genetics 🌐 English ⚖ 641 KB

Cancer risks in first-degree relatives o

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

✍ Gronwald, J; Cybulski, C; Piesiak, W; Suchy, J; Huzarski, T; Byrski, T; Gorski, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

Effect of CHEK2 missense variant I157T o

Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations

✍ Cybulski, C; Gorski, B; Huzarski, T; Byrski, T; Gronwald, J; Debniak, T; Wokolor 📂 Article 📅 2008 🏛 BMJ Publishing Group 🌐 English ⚖ 165 KB

CHEK2 mutations as markers for high risk

CHEK2 mutations as markers for high risk of breast cancer

✍ Cezary Cybulski; Dominika Wokołorczyk; Anna Jakubowska; Tomasz Huzarski; Tomasz 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 75 KB

CHEK2 mutations and HNPCC-related colore

CHEK2 mutations and HNPCC-related colorectal cancer

✍ Janina Suchy; Cezary Cybulski; Dominika Wokołorczyk; Oleg Oszurek; Bohdan Górski 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 128 KB

## Abstract Recently, the 1100delC variant of cell cycle checkpoint kinase 2 (CHEK2) has been reported to confer a colorectal cancer risk in hereditary non‐polyposis‐colorectal cancer (HNPCC) and HNPCC‐related families in the Netherlands. To investigate whether CHEK2 mutations confer increased canc